Literature DB >> 8512094

A prospective, comparative trial of three anesthetics for elective supratentorial craniotomy. Propofol/fentanyl, isoflurane/nitrous oxide, and fentanyl/nitrous oxide.

M M Todd1, D S Warner, M D Sokoll, M A Maktabi, B J Hindman, F L Scamman, J Kirschner.   

Abstract

BACKGROUND: Different anesthetic agents have different effects on cerebrovascular physiology. However, the importance of these differences in neuroanesthetic practice are unclear. In an effort to determine whether important clinical differences are present, the authors compared three anesthetic techniques in 121 adults undergoing elective surgical removal of a supratentorial, intracranial mass lesion.
METHODS: Patients were assigned randomly to one of three groups. In group 1 (n = 40), anesthesia was induced with propofol and maintained with fentanyl (approximately 10 micrograms/kg load, 2-3 micrograms.kg-1.h-1 infusion) and propofol (50-300 micrograms.kg-1.min-1). In group 2 (n = 40), anesthesia was induced with thiopental and maintained with isoflurane and nitrous oxide. Up to 2 micrograms/kg fentanyl was given after replacement of the bone flap. In group 3 (n = 41), anesthesia was induced with thiopental and maintained with fentanyl (approximately 10 micrograms/kg load, 2-3 micrograms.kg-1.h-1 infusion), nitrous oxide, and low-dose isoflurane, if required. Blood pressure, heart rate, expired gas concentrations, and ventilatory parameters were recorded automatically in all patients. Epidural intracranial pressure (ICP) was measured via the first burr hole, brain swelling was rated at the time of dural opening, and emergence was monitored closely. Preoperative computed tomography or magnetic resonance imaging scans were evaluated, and pre- and postoperative neurologic exams were performed by a neurosurgeon unaware of group assignments. Total hospital stay (days) and total hospital cost (exclusive of physician charges) also were reviewed.
RESULTS: During induction, higher heart rates were seen in isoflurane/nitrous oxide patients, whereas mean arterial pressure was approximately 10 mmHg less during the maintenance phase (compared with both other groups). Otherwise, there were few intergroup hemodynamic differences. While there were no clinically important intergroup differences in mean ICP (+/- SD)-group 1, ICP = 12 +/- 7 mmHg; group 2, 15 +/- 12 mmHg; group 3, ICP = 11 +/- 8 mmHg-more isoflurane/nitrous oxide patients (nine, group 2) had an ICP > or = 24 mmHg than in the other groups (two each). Emergence was, overall, more rapid with fentanyl/nitrous oxide. For example, the median time until the patient could be awakened by quiet verbal command, e.g., "Open your eye," was 5 min, versus 10 min in the other groups. There were no relationships between ICP and any measurement of emergence (e.g., time to response to commands). Seven of 41 (17%) fentanyl/nitrous oxide patients vomited in the early postoperative period, compared with only 1 of 40 (2.5%) of those given propofol/fentanyl and 2 of 40 (5%) receiving isoflurane/nitrous oxide (P = 0.03). There were no differences in the incidence of new postoperative deficits, total hospital stay, or cost.
CONCLUSIONS: Although there are modest differences among the three tested anesthetics, short-term outcome was not affected. These results indicate that, despite their respective cerebrovascular effects, all of the anesthetic regimens used were acceptable in these patients undergoing elective surgery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512094     DOI: 10.1097/00000542-199306000-00002

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  28 in total

Review 1.  General anaesthesia for supratentorial neurosurgery.

Authors:  P Ravussin; O Wilder-Smith
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Anesthesia for epilepsy surgery in children.

Authors:  Sulpicio G Soriano; Patrizia Bozza
Journal:  Childs Nerv Syst       Date:  2006-06-20       Impact factor: 1.475

3.  Gender rather than choice of intermediate duration opioids affects emergence after craniotomy for large intracranial tumors.

Authors:  Anupa Deogaonkar; Mimi Khin; Samuel Samuel; Zeyd Y Ebrahim; Edward J Mascha; Armin Schubert
Journal:  Ochsner J       Date:  2011

4.  Comparison of propofol and desflurane for postanaesthetic morbidity in patients undergoing surgery for aneurysmal SAH: a randomized clinical trial.

Authors:  Avanish Bhardwaj; Hemant Bhagat; Vinod Kumar Grover; Nidhi Bidyut Panda; Kiran Jangra; Seelora Sahu; Navneet Singla
Journal:  J Anesth       Date:  2018-03-01       Impact factor: 2.078

Review 5.  Induction of anaesthesia: a guide to drug choice.

Authors:  Nathalie Nathan; Isabelle Odin
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Comparison of equiosmolar hypertonic saline and mannitol for brain relaxation during craniotomies: A meta-analysis of randomized controlled trials.

Authors:  Jingxue Fang; Yanzhang Yang; Wei Wang; Yang Liu; Tong An; Meijuan Zou; Gang Cheng
Journal:  Neurosurg Rev       Date:  2017-03-03       Impact factor: 3.042

7.  A case of delayed emergence from anesthesia caused by postoperative brain edema associated with unexpected cerebral venous sinus thrombosis.

Authors:  Yuko Kozasa; Hikari Takaseya; Yukari Koga; Teruyuki Hiraki; Yasunori Mishima; Shuhei Niiyama; Kazuo Ushijima
Journal:  J Anesth       Date:  2013-03-23       Impact factor: 2.078

8.  A Comparative Study of Propofol and Isoflurane Anaesthesia using Butorphanol in Neurosurgery.

Authors:  Ld Mishra; N Rajkumar; Sn Singh; Rk Dubey; G Yadav
Journal:  Indian J Anaesth       Date:  2009-06

Review 9.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

10.  Anaesthesiological strategies in elective craniotomy: randomized, equivalence, open trial--the NeuroMorfeo trial.

Authors:  Giuseppe Citerio; Maria Grazia Franzosi; Roberto Latini; Serge Masson; Simona Barlera; Stefano Guzzetti; Antonio Pesenti
Journal:  Trials       Date:  2009-04-06       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.